(1) The chief health officer may keep a database (the monitored medicines database ) to record information relating to monitored medicines.
(2) The monitored medicines database may be kept in any form, including electronically, that the chief health officer decides.
(3) The chief health officer may—
(a) correct an error or omission in the monitored medicines database; and
(b) change information included in the database to keep the database accurate and up-to-date.
(4) The monitored medicines database may include the following:
(a) required information about the supply of a monitored medicine under a supply authority;
(b) information about the approval to prescribe a monitored medicine;
(c) information from another jurisdiction in relation to the supply or prescription of a monitored medicine in the other jurisdiction;
(d) information in relation to a monitored medicine from an approved data source entity;
(e) any other information prescribed by regulation.